Want to see AU:BUB full AI Analyst Report?
BUB Stock Chart & Stats
AU$0.09
>-AU$0.01(-1.27%)
At close: 4:00 PM EDT
AU$0.09
>-AU$0.01(-1.27%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.17
Previous CloseN/A
Volume923.77K
Average Volume (3M)2.80M
Market Cap
AU$85.93M
Enterprise ValueAU$75.33M
Total Cash (Recent Filing)AU$9.41M
Total Debt (Recent Filing)AU$15.92M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Mar 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding895,130,070
10 Day Avg. Volume2,169,291
30 Day Avg. Volume2,799,332
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.76
Price to Sales (P/S)0.62
P/FCF Ratio-4.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.17Price Target Upside88.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$124.45M
Bulls Say, Bears Say
Bulls Say
U.S. Growth And DistributionRapid U.S. growth and broader retail access strengthen Bubs’ market position in its largest geography. Expanded distribution can improve brand visibility, support repeat purchases, and provide a durable platform for future product launches and operating leverage.
Sustained Revenue GrowthContinued top-line expansion indicates that customer demand and market reach are progressing despite disruptions and cost pressure. A larger revenue base can support marketing, distribution investment, and fixed-cost absorption if growth remains sustained over coming periods.
Underlying Profitability And EfficiencyPositive underlying EBITDA alongside identified operating savings suggests the business has a path toward better earnings quality beneath reported one-off costs. Sustained efficiency gains could help rebuild margins and improve the scalability of future revenue growth.
Bears Say
Persistent Cash OutflowsDeeply negative operating and free cash flow weaken self-funding capacity and increase reliance on balance-sheet resources or external financing. Unless cash conversion improves, ongoing growth investment may remain difficult to sustain and financial flexibility could narrow.
Volatile Profitability And Margin PressureThe return to losses and significant gross-margin compression show that revenue growth has not yet translated into durable earnings. Continued cost pressure could limit reinvestment, weaken resilience, and make future results more sensitive to product mix and operating execution.
Competitive And Demographic PressureIntense competition and declining birth rates create structural limits on category volume and make customer acquisition harder. Bubs must continue differentiating premium products and investing in brands to protect share, which can constrain margins and raise execution demands.
Bubs Australia Ltd. News
BUB FAQ
What was Bubs Australia Ltd.’s price range in the past 12 months?
Bubs Australia Ltd. lowest share price was AU$0.08 and its highest was AU$0.17 in the past 12 months.
What is Bubs Australia Ltd.’s market cap?
Bubs Australia Ltd.’s market cap is AU$85.93M.
When is Bubs Australia Ltd.’s upcoming earnings report date?
Bubs Australia Ltd.’s upcoming earnings report date is Mar 01, 2027 which is in 133 days.
How were Bubs Australia Ltd.’s earnings last quarter?
Bubs Australia Ltd. released its earnings results on Aug 26, 2026. The company reported -AU$0.01 earnings per share for the quarter.
Is Bubs Australia Ltd. overvalued?
According to Wall Street analysts Bubs Australia Ltd.’s price is currently Undervalued.
Does Bubs Australia Ltd. pay dividends?
Bubs Australia Ltd. does not currently pay dividends.
What is Bubs Australia Ltd.’s EPS estimate?
Bubs Australia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bubs Australia Ltd. have?
Bubs Australia Ltd. has 895,130,070 shares outstanding.
What happened to Bubs Australia Ltd.’s price movement after its last earnings report?
Bubs Australia Ltd. reported an EPS of -AU$0.01 in its last earnings report. Following the earnings report the stock price went down -7.527%.
Which hedge fund is a major shareholder of Bubs Australia Ltd.?
Currently, no hedge funds are holding shares in AU:BUB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bubs Australia Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.17 (88.89% Upside)
AU$0.17 (88.89% Upside)
Blogger Sentiment
Bearish
AU:BUB Sentiment 63%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth AU$383.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.79%
12-Months-Change
Fundamentals
Return on Equity
-11.08%
Trailing 12-Months
Asset Growth
26.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bubs Australia Ltd.
Bubs Australia Limited, together with its subsidiaries, manufactures and sell infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. The company offers goat and cow milk infant formulas, goat milk powder products for adults, and fresh dairy products. It also provides organic baby food, cereals, toddler snacks, and chilled goat milk. In addition, the company holds IP and trademarks. It sells its products under the Bubs and Caprilac brands. The company exports its products to China, Japan, Singapore, Malaysia, Vietnam, the Middle East, and North America. Bubs Australia Limited was founded in 2005 and is based in Dandenong, Australia.
BUB Stock 12 Month Forecast
Average Price Target
AU$0.17
▲(88.89% Upside)
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Nuchev Pty Ltd
―
Nutritional Growth Solutions Ltd.
―
Clover Corporation Limited
―